tiprankstipranks
Advertisement
Advertisement
Icon price target raised to $180 from $165 at Citi
PremiumThe FlyIcon price target raised to $180 from $165 at Citi
12d ago
Icon Plc: Sell Rating Reiterated as Margin Upside Limited and Shares Trade Above Raised $160 Price Target
Premium
Ratings
Icon Plc: Sell Rating Reiterated as Margin Upside Limited and Shares Trade Above Raised $160 Price Target
12d ago
ICON Restructures Debt and Divests Symphony Ahead of Note Maturities
Premium
Company Announcements
ICON Restructures Debt and Divests Symphony Ahead of Note Maturities
13d ago
Is ICLR a Buy, Before Earnings?
PremiumPre-EarningsIs ICLR a Buy, Before Earnings?
16d ago
ICON Sets Dates for Q2 2026 Earnings Release and Investor Call
Premium
Company Announcements
ICON Sets Dates for Q2 2026 Earnings Release and Investor Call
21d ago
SERAFA-1 Trial Update: AstraZeneca and Icon Deepen Their Breast Cancer Bet
Premium
Company Announcements
SERAFA-1 Trial Update: AstraZeneca and Icon Deepen Their Breast Cancer Bet
1M ago
Icon upgraded to Outperform from Sector Perform at RBC Capital
PremiumThe FlyIcon upgraded to Outperform from Sector Perform at RBC Capital
2M ago
Icon price target raised to $187 from $160 at BMO Capital
Premium
The Fly
Icon price target raised to $187 from $160 at BMO Capital
2M ago
Icon price target raised to $155 from $130 at JPMorgan
Premium
The Fly
Icon price target raised to $155 from $130 at JPMorgan
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100